These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3652470)

  • 1. Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas.
    D'Emden MC; Harrison LC
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):697-702. PubMed ID: 3652470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid improvement of visual defects with parenteral depot-bromocriptine in a patient with a non-functioning pituitary adenoma.
    García-Luna PP; Leal-Cerro A; Pereira JL; Montero C; Acosta D; Trujillo F; Mazuelos C; Astorga R
    Horm Res; 1989; 32(5-6):183-7. PubMed ID: 2634611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
    Kahn SE; Miller JL
    S Afr Med J; 1982 Oct; 62(19):696-9. PubMed ID: 7135127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
    Yamashita M; Hirakawa T; Tashiro Y; Matsuda T; Kibe M; Fukushima T; Tomonaga M
    No Shinkei Geka; 1987 Jan; 15(1):65-72. PubMed ID: 3822068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of pituitary prolactinoma after treatment with bromocriptine.
    Landolt AM; Wüthrich R; Fellmann H
    Lancet; 1979 May; 1(8125):1082-3. PubMed ID: 86800
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent use of bromocriptine and fluphenazine.
    Kellner C; Harris P; Blumhardt C
    J Clin Psychiatry; 1985 Oct; 46(10):455. PubMed ID: 4044540
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complete regression of prolactin-secreting pituitary tumors by bromocriptine therapy (author's transl)].
    Munemitsu H; Matsuda M; Hirai O; Kawamura J; Matsubayashi K; Fukuyama H
    No Shinkei Geka; 1980 Oct; 8(10):981-6. PubMed ID: 7442930
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine in management of large pituitary tumours.
    Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
    Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dopamine agonist therapy on large functionless pituitary tumours.
    Grossman A; Ross R; Charlesworth M; Adams CB; Wass JA; Doniach I; Besser GM
    Clin Endocrinol (Oxf); 1985 May; 22(5):679-86. PubMed ID: 4028461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen.
    Völker W; Gehring WG; Berning R; Schmidt RC; Schneider J; von zur Mühlen A
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):491-500. PubMed ID: 7158226
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
    Grimson BS; Bowman ZL
    Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of extra-sellar pituitary tumours with bromocriptine: comparison of prolactin secreting and non-functioning tumours using half-field visual evoked potentials and computerised tomography.
    Pullan PT; Carroll WM; Chakera TM; Khangure MS; Vaughan RJ
    Aust N Z J Med; 1985 Apr; 15(2):203-8. PubMed ID: 3861164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine.
    Bevan JS; Burke CW
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):561-72. PubMed ID: 3621623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy.
    Maeda T; Ushiroyama T; Okuda K; Fujimoto A; Ueki M; Sugimoto O
    Obstet Gynecol; 1983 Jan; 61(1):117-21. PubMed ID: 6823341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma.
    Cabeza GA; Flores LF; Iñiguez IE; Calarco ZE; Valencia PF
    Rev Invest Clin; 1984; 36(2):147-9. PubMed ID: 6484333
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
    Zárate A; Morán C; Klériga E; Loyo M; González-Angulo A; Aquilar-Parada E
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):445-50. PubMed ID: 3993311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
    Verde G; Oppizzi G; Chiodini PG; Dallabonzana D; Luccarelli G; Liuzzi A
    J Endocrinol Invest; 1985 Apr; 8(2):113-5. PubMed ID: 4031376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
    Lesser RL; Zheutlin JD; Boghen D; Odel JG; Robbins RJ
    Am J Ophthalmol; 1990 May; 109(5):535-43. PubMed ID: 2333917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine therapy for non-functioning pituitary adenoma.
    van Schaardenburg D; Roelfsema F; van Seters AP; Vielvoye GJ
    Clin Endocrinol (Oxf); 1989 May; 30(5):475-84. PubMed ID: 2605786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.